Andrew Douglas

Andrew Douglas is a Senior Clinical Research Fellow at the Nuffield Department of Clinical Neuroscience, University of Oxford, and serves as a consultant in clinical genetics at the Oxford Centre for Genomic Medicine. His work bridges clinical practice and genetic research, specializing in motor neuron disease (MND) with a focus on familial and sporadic cases involving known gene mutations.

His research centers on neurogenetics, particularly MND penetrance mechanisms and risk prediction modeling for at-risk relatives. He investigates genetic variability in neurodegenerative/neuromuscular disorders, RNA splicing dysregulation, and oligonucleotide-based therapeutic development. Current projects aim to identify protective genetic factors that could inform novel treatments and improve genetic counseling accuracy.

Analysis of his 2024-2025 publications reveals consistent emphasis on genetic testing methodologies, penetrance quantification, and ethical challenges in MND/ALS. His work integrates clinical neurology with molecular genetics to advance personalized risk assessment frameworks, particularly for asymptomatic family members in mutation-positive lineages.

Scientific Awards:

• No scientific awards mentioned in source text

Advising and Grants:

• No student advisees or grant funding details specified

Labs and Teams: Dr. Douglas is a core member of the Oxford Motor Neuron Disease Centre, collaborating on translational research initiatives within the University of Oxford's neuroscience ecosystem to develop genetic risk models and therapeutic strategies.